P rimary leiomyosarcoma (LMS) of thyroid is rare malignant neoplasm usually seen in elderly patients. These tumours are characterised by a rapidly growing mass in the neck, difficult to diagnose preoperatively and are highly aggressive with high recurrence rates in spite of radical surgery, chemotherapy and radiotherapy. We herein report a case of 50-year-old female with a rapidly growing painless mass in the neck. Total thyroidectomy with bilateral neck node clearance was done. Histology and Immunohistochemistry revealed primary LMS of thyroid gland. Within 1 month of radical surgery she developed local recurrence. Diagnosis of primary LMS is difficult and immunohistochemistry is necessary to differentiate it from other malignancies of the thyroid. Primary LMS remains a life-threatening tumour and more effective treatment are needed to improve outcome.
Malignancies of the thyroid are one of the most common neoplasms and predominantly affect females. Differentiated thyroid carcinomas include papillary and follicular carcinomas (accounting for 90-95% of all cases). 1 Papillary carcinoma is the most common type of all thyroid malignancies, while medullary thyroid carcinoma comprises 6% of all cases. 1 Rarer types include anaplastic carcinomas, lymphomas and sarcomas. 2 Among these, sarcomas are an extremely rare groups of tumours. 1 The sarcoma types observed in the thyroid glands are liposarcoma, leiomyosarcoma (LMS), and angiosarcoma. Primary LMS of the thyroid is a rare tumour and approximately only 30 cases have been reported previously. [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] The other common sites for LMS are gastrointestinal tract, retroperitoneum and pelvis. 23 According to the histological tumour classification by World Health Organization (WHO), thyroid LMS is classified as a member of the smooth-muscle tumours of thyroid gland. 24 An accurate diagnosis requires combined clinical, imaging, histological and immunohistochemistry evaluations. 15 The prognosis is generally poor in spite of aggressive surgery, adjuvant radiotherapy and chemotherapy, and recurrence/relapse rates are very high with an estimated 1-year survival of only 5-10%. 20 We herein report a case of 50-year-old female with primary LMS of thyroid with aggressive presentation.
Case presentation
A 50-year-old female presented to us with a 3-week history of rapidly progressive neck swelling associated with mild neck discomfort. She did not complain of any respiratory difficulty, voice change, haemoptysis, dysphagia, weight loss, loss of appetite or fever. She had no previous history of radiation exposure, no significant medical illness or surgery, and no family history of thyroid Ultrasonography-guided fine needle aspiration cytology was suggestive for malignancy, possibly medullary carcinoma/poorly differentiated carcinoma (Bethesda category VI). Her serum calcitonin and urine catecholamines levels were within normal limits.
After detailed discussion and consent she underwent total thyroidectomy and bilateral neck A positron emission tomography scan conducted postoperatively and showed no evidence of residual tissue and distant metastasis. The patient was then planned for radiotherapy after stabilisation; however, within 1 month of the waiting period, she developed local recurrence.
The oncology team were consulted and she received 35 cycles of radiotherapy and paclitaxel and carboplatin-based chemotherapy.
During last follow-up telephonically 5 months post-surgery she was alive;
however, in a very poor general condition.
Discussion
Primary LMS of the thyroid gland is a rare tumour. Among all tumours of the thyroid gland, primary thyroid LMS accounts only for 0.014%.
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They usually develop in older people (mean age 66 years) with no gender predisposition. 20 Primary thyroid LMS most commonly presents as a painless, rapidly-growing neck mass. Onset of tumour, which usually develops in one lobe of the thyroid, is sudden and the tumour spreads rapidly to surrounding tissues as seen in our case. 18 Additional symptoms may include hoarseness, dysphagia, dyspnoea and weight loss. The aetiology of these tumours is not very clear; however, they are thought to develop from the smooth muscles of the capsular veins in the thyroid gland. 24 It is also suggested that primary thyroid LMS may develop as a result of smooth muscle metaplasia in a thyroid anaplastic carcinoma. 25 Infection with Epstein-Barr virus is also suspected in a previous case report. 6 In contrast to anaplastic carcinoma of the thyroid, cervical metastasis is less common in LMS. Distant metastasis has been reported in lungs, lymph nodes, liver, myocardium, kidney, pancreas, small bowel, colon, peritoneum, brain, and bones. 20 Histological features are typically the presence of interlacing fascicles or bundles of eosinophilic spindle cells with abundant acidophilic fibrillary cytoplasm and with a nucleus generally centrally located and typically blunt-ended or 'cigar-shaped'. The degree of nuclear atypia, as well as the mitotic activity, varies considerably. Although high mitotic index is virtually diagnostic of malignancy, a primary thyroid LMS must be strongly suspected for a tumour that is widely necrotic, haemorrhagic and with significant atypia, even if the mitotic activity is low. 15 On Immunohistochemistry, positivity for smooth muscle actin, vimentin, desmin and caldesmon may diagnose thyroid LMS, while these tumour cells don't react to keratin, thyroglobulin, chromogranin, and calcitonin. shown a positive effect on the high recurrence rate and poor survival of these tumours. 16 A recent review of published cases indicated that 14 out of 23 patients died within months; four of the seven who survived had a recurrent and/or metastatic disease. Among these, the longest duration of the patient to be disease-free was 5 years. 18 In conclusion, as primary LMS is a rare malignancy of the thyroid, it should be suspected in all patients presenting with rapidly growing mass at the anterior neck. Early diagnosis and intervention are crucial, and immunohistochemistry is necessary to differentiate it from other aggressive malignancies of thyroid. LMS is an aggressive tumour with poor prognosis and without any established treatment. q
